Spasmodic dysphonia and botulinum toxin: Experience from the largest treatment series

European Journal of Neurology

Volumn 17, Issue SUPPL. 1, 2010, Pages 28-30

  Blitzer, A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ANTIPARKINSON AGENT; BOTULINUM TOXIN;

ADULT; ANAMNESIS; CLINICAL FEATURE; CONFERENCE PAPER; COUGHING; DRUG TOLERABILITY; ELECTROMYOGRAPHY; HUMAN; PAIN; PRIORITY JOURNAL; PRURITUS; PSYCHOTHERAPY; SKIN BRUISING; SPASMODIC DYSPHONIA; SPEECH THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; DYSPHONIA; INTRAMUSCULAR DRUG ADMINISTRATION;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; DYSPHONIA; ELECTROMYOGRAPHY; HUMANS; INJECTIONS, INTRAMUSCULAR;

EID: 77953336664     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03047.x     Document Type: Conference Paper

References (19)

1. Asgeirsson H, Jakobsson F, Hjaltason H, Jonsdottir H, Sveinbjornsdottir S. Prevalence study of primary dystonia in Iceland. Mov Disord 2006 21 : 293 298.
2. Aronson AE. Clinical Voice Disorders., NY: Thieme Med Publ, 1985: 5258.
3. Cannito MP, Johnson P. Spastic dysphonia: a continuum disorder. J Commun Disord 1981 14 : 215 223.
4. Chitkara A, Meyer T, Keidar A, Blitzer A. Singer's dystonia: first report of a variant of spasmodic dysphonia. Ann Otol Rhinol Laryngol 2006 115 : 89 92.
5. Grillone GA, Blitzer A, Brin MF, et al. Treatment of adductor laryngeal breathing dystonia with botulinum toxin type A. Laryngoscope 1994 104 : 30 32.
6. Dedo HH. Recurrent laryngeal nerve section for spasmodic dysphonia. Ann Otol Rhinol Laryngol 1976 85 : 451 459.
7. Biller HF, Som ML, Lawson W. Laryngeal nerve crush for spastic dysphonia. Ann Otol Rhinol Laryngol 1979 88 : 531 532.
8. Netterville JL, Stone RE, Rainey C, et al. Recurrent nerve avulsion for the treatment of spastic dysphonia. Ann Otol Rhinol Laryngol 1991 100 : 10 14.
9. Shiratzki H, Fritzell B. Treatment of spasmodic dysphonia by means of resection of the recurrent laryngeal nerve. Acta Otolaryngol Suppl 1988 449 : 115 117.
10. Aronson AE, DeSanto LW. Adductor spastic dysphonia three years after recurrent laryngeal nerve section. Laryngoscope 1983 93 : 1 8.
11. Biller HF, Som ML, Lawson W. Laryngeal nerve crunch for spastic dysphonia. Ann Otol Rhinol Laryngol 1983 92 : 469.
12. Fritzell B, Hammarberg B, Schiratzki H, et al. Long-term results of recurrent laryngeal nerve resection for adductor spasmodic dysphonia. J Voice 1993 7 : 172 178.
13. Berke GS, Blackwell KE, Gerratt BR, et al. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia. Ann Otol Rhinol Laryngol 1999 108 : 227 231.
14. Blitzer A, Brin M, Fahn S, Lovelace RE. The use of Botulinum toxin in the treatment of focal laryngeal dystonia (spastic Dysphonia). Laryngoscope 1988 98 : 193.
15. Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients. Laryngoscope 1998 108 : 1435 1441.
16. Blitzer A, Brin MF, Stewart C, Fahn S. Abductor laryngeal dystonia: a series treated with Botulinum toxin. Laryngoscope 1992 102 : 163 167.
17. Sulica L, Blitzer A, Brin MF, Stewart CF. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section. Ann Otol Rhinol Laryngol 2003 112 : 499 505.
18. Gilio F, Curra A, Lorenzano C, et al. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia. Ann Neurol 2000 48 : 20 26.
19. Cyrus CB, Bielamowicz S, Evans FJ, Ludlow CL. Adductor muscle activity abnormalities in abductor spasmodic dysphonia. Otolaryngol Head Neck Surg 2001 124 : 23 30.